article · Infection and Drug Resistance
Background: Biofilm-related infections represent one of the major challenging health problems that enhances antimicrobial resistance with subsequent treatment failure of catheter-associated urinary tract infections (CAUTIs). Aim: This study aimed to employ and comprehensively characterize the use of nanoparticles to inhibit bacterial biofilm formation. Zinc oxide nanoparticles (ZnO-NPs) are considered one of the most important biofilm inhibitors. Methods: The current study aimed to characterize the influence of the bioreductive green synthesis of ZnO-NPs using pomegranate peel extract on bacterial colonization to protect against urinary catheter infections. ZnO-NPs were investigated for their physicochemical properties using UV, FTIR, Dynamic light scattering, and TEM. Catheters were coated with ZnO-NPs using Pistacia lentiscus (mastic), and the slow release of free zinc ions (Zn +2 ) from, the ZnO-NPs-coated catheters, was evaluated using the ICP-AES technique. Results: The current study revealed that catheter coated by ZnO-NPs exhibited a sustained antibiofilm activity against biofilm-forming and antibiotic-resistant clinical isolates of Staphylococcus epidermidis, Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis , and Pseudomonas aeruginosa strains. Conclusion: The present study supports the efficiency of ZnO-NPs as a good candidate for prevention of biofilm formation. Keywords: urinary catheters, biofilm, bacterial colonization, zinc oxide nanoparticles, catheter associated infection
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.2147/idr.s509957
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.